ReP USP - Resultado da busca

Artigo de periodico
Assessment of Culture and Laboratory Practices Related to Patient Safety in Brazilian Laboratories (2022)
Shcolnik, Wilson; Duarte, Alberto Jose da Silva
Fonte: Journal of patient safety. Unidade: FM
Assuntos: PSICOMETRIA, INDICADORES DE QUALIDADE, LABORATÓRIOS DE SAÚDE PÚBLICA, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SHCOLNIK, Wilson e DUARTE, Alberto Jose da Silva. Assessment of Culture and Laboratory Practices Related to Patient Safety in Brazilian Laboratories. Journal of patient safety, v. 18, n. 7, p. 674-679, 2022Tradução . . Disponível em: https://doi.org/10.1097/PTS.0000000000000981. Acesso em: 10 nov. 2024.
APA
Shcolnik, W., & Duarte, A. J. da S. (2022). Assessment of Culture and Laboratory Practices Related to Patient Safety in Brazilian Laboratories. Journal of patient safety, 18( 7), 674-679. doi:10.1097/PTS.0000000000000981
NLM
Shcolnik W, Duarte AJ da S. Assessment of Culture and Laboratory Practices Related to Patient Safety in Brazilian Laboratories [Internet]. Journal of patient safety. 2022 ; 18( 7): 674-679.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1097/PTS.0000000000000981
Vancouver
Shcolnik W, Duarte AJ da S. Assessment of Culture and Laboratory Practices Related to Patient Safety in Brazilian Laboratories [Internet]. Journal of patient safety. 2022 ; 18( 7): 674-679.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1097/PTS.0000000000000981
Artigo de periodico
A common variant close to the “tripwire” linker region of NLRP1 contributes to severe COVID-19 (2022)
Leal, Vinicius Nunes Cordeiro ; Cambui, Raylane Adrielle Gonçalves ; Zupelli, Thiago Gameiro ; Yamada, Suemy Melim ; Oliveira, Leonardo Antonio Teixeira de ; Andrade, Milena Mary de Souza ; Teixeira, Franciane Mouradian Emílio ; Custódio, Ricardo Wesley Alberca ; Silva, Sarah Cristina Gozzi e ; Yendo, Tatiana Mina ; Netto, Lucas Chaves ; Duarte, Alberto José da Silva; Sato, Maria Notomi ; Pontillo, Alessandra
Fonte: Inflammation Research. Unidades: FM, ICB
Assuntos: IMUNOLOGIA, ESTUDOS DE COORTES, VARIAÇÃO GENÉTICA, COVID-19, FATORES DE RISCO, NUCLEOTÍDEOS, CITOCINAS, INFLAMAÇÃO, ENZIMAS PROTEOLÍTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Vinicius Nunes Cordeiro et al. A common variant close to the “tripwire” linker region of NLRP1 contributes to severe COVID-19. Inflammation Research, p. 1-8, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00011-022-01670-3. Acesso em: 10 nov. 2024.
APA
Leal, V. N. C., Cambui, R. A. G., Zupelli, T. G., Yamada, S. M., Oliveira, L. A. T. de, Andrade, M. M. de S., et al. (2022). A common variant close to the “tripwire” linker region of NLRP1 contributes to severe COVID-19. Inflammation Research, 1-8. doi:10.1007/s00011-022-01670-3
NLM
Leal VNC, Cambui RAG, Zupelli TG, Yamada SM, Oliveira LAT de, Andrade MM de S, Teixeira FME, Custódio RWA, Silva SCG e, Yendo TM, Netto LC, Duarte AJ da S, Sato MN, Pontillo A. A common variant close to the “tripwire” linker region of NLRP1 contributes to severe COVID-19 [Internet]. Inflammation Research. 2022 ; 1-8.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1007/s00011-022-01670-3
Vancouver
Leal VNC, Cambui RAG, Zupelli TG, Yamada SM, Oliveira LAT de, Andrade MM de S, Teixeira FME, Custódio RWA, Silva SCG e, Yendo TM, Netto LC, Duarte AJ da S, Sato MN, Pontillo A. A common variant close to the “tripwire” linker region of NLRP1 contributes to severe COVID-19 [Internet]. Inflammation Research. 2022 ; 1-8.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1007/s00011-022-01670-3
Artigo de periodico
Clinical features of COVID-19 by SARS-CoV-2 Gamma variant: a prospective cohort study of vaccinated and unvaccinated healthcare workers (2022)
Luna-Muschi, Alessandra; Borges, Igor C; Faria, Elizabeth de; Barboza, Antonio S; Maia, Fernando L; Leme, Mariana D; Guedes, Ana Rubia; Correa, Maria Cássia Jacintho Mendes ; Kallas, Esper Georges ; Segurado, Aluisio Augusto Cotrim ; Sabino, Ester Cerdeira ; Levin, Anna Sara Shafferman ; Costa, Sílvia Figueiredo
Fonte: Journal of infection. Unidades: FM, RUSP
Assuntos: ARTIGOS DE PERIÓDICOS, VACINAÇÃO, COVID-19, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUNA-MUSCHI, Alessandra et al. Clinical features of COVID-19 by SARS-CoV-2 Gamma variant: a prospective cohort study of vaccinated and unvaccinated healthcare workers. Journal of infection, v. 84, n. 2, p. 262-265, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jinf.2021.09.005. Acesso em: 10 nov. 2024.
APA
Luna-Muschi, A., Borges, I. C., Faria, E. de, Barboza, A. S., Maia, F. L., Leme, M. D., et al. (2022). Clinical features of COVID-19 by SARS-CoV-2 Gamma variant: a prospective cohort study of vaccinated and unvaccinated healthcare workers. Journal of infection, 84( 2), 262-265. doi:10.1016/j.jinf.2021.09.005
NLM
Luna-Muschi A, Borges IC, Faria E de, Barboza AS, Maia FL, Leme MD, Guedes AR, Correa MCJM, Kallas EG, Segurado AAC, Sabino EC, Levin ASS, Costa SF. Clinical features of COVID-19 by SARS-CoV-2 Gamma variant: a prospective cohort study of vaccinated and unvaccinated healthcare workers [Internet]. Journal of infection. 2022 ; 84( 2): 262-265.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.jinf.2021.09.005
Vancouver
Luna-Muschi A, Borges IC, Faria E de, Barboza AS, Maia FL, Leme MD, Guedes AR, Correa MCJM, Kallas EG, Segurado AAC, Sabino EC, Levin ASS, Costa SF. Clinical features of COVID-19 by SARS-CoV-2 Gamma variant: a prospective cohort study of vaccinated and unvaccinated healthcare workers [Internet]. Journal of infection. 2022 ; 84( 2): 262-265.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.jinf.2021.09.005
Artigo de periodico
Adherence to non-pharmacological preventive measures among healthcare workers in a middle-income country during the first year of the COVID-19 pandemic: Hospital and community setting (2022)
Costa, Sílvia Figueiredo ; Vernal, Sebastian; Giavina-Bianchi Júnior, Pedro Francisco ; Peres, Carlos Henrique Mesquita; Santos, Lanuse G. D. dos; Duarte, Alberto José da Silva; Bonfa, Eloisa Silva Dutra de Oliveira ; Sabino, Ester Cerdeira ; Segurado, Aluisio Augusto Cotrim ; Levin, Anna Sara Shafferman
Fonte: American journal of infection control. Unidade: FM
Assuntos: COVID-19, ADESÃO À MEDICAÇÃO, TRABALHADORES, PREVENÇÃO DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Sílvia Figueiredo et al. Adherence to non-pharmacological preventive measures among healthcare workers in a middle-income country during the first year of the COVID-19 pandemic: Hospital and community setting. American journal of infection control, v. 50, n. 6, p. 707-711, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ajic.2021.12.004. Acesso em: 10 nov. 2024.
APA
Costa, S. F., Vernal, S., Giavina-Bianchi Júnior, P. F., Peres, C. H. M., Santos, L. G. D. dos, Duarte, A. J. da S., et al. (2022). Adherence to non-pharmacological preventive measures among healthcare workers in a middle-income country during the first year of the COVID-19 pandemic: Hospital and community setting. American journal of infection control, 50( 6), 707-711. doi:10.1016/j.ajic.2021.12.004
NLM
Costa SF, Vernal S, Giavina-Bianchi Júnior PF, Peres CHM, Santos LGD dos, Duarte AJ da S, Bonfa ESD de O, Sabino EC, Segurado AAC, Levin ASS. Adherence to non-pharmacological preventive measures among healthcare workers in a middle-income country during the first year of the COVID-19 pandemic: Hospital and community setting [Internet]. American journal of infection control. 2022 ; 50( 6): 707-711.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.ajic.2021.12.004
Vancouver
Costa SF, Vernal S, Giavina-Bianchi Júnior PF, Peres CHM, Santos LGD dos, Duarte AJ da S, Bonfa ESD de O, Sabino EC, Segurado AAC, Levin ASS. Adherence to non-pharmacological preventive measures among healthcare workers in a middle-income country during the first year of the COVID-19 pandemic: Hospital and community setting [Internet]. American journal of infection control. 2022 ; 50( 6): 707-711.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.ajic.2021.12.004
Artigo de periodico
Antiviral response induced by toll-like receptor (TLR) 7/TLR8 activation inhibits human immunodeficiency virus Type 1 infection in cord blood macrophages (2022)
Pietrobon, Anna Julia ; Yoshikawa, Fábio Setti Yamada ; Oliveira, Luana Maia; Pereira, Natalli Zanete ; Souza, Taís Aparecida Matozo de ; Bargieri, Bruna Cunha de Alencar ; Duarte, Alberto José da Silva; Sato, Maria Notomi
Fonte: Journal of Infectious Diseases. Unidades: ICB, FM
Assuntos: IMUNOLOGIA, ADJUVANTES IMUNOLÓGICOS, HIV, INFECÇÕES POR HIV, RECÉM-NASCIDO, MACRÓFAGOS, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, INTERFERON TIPO I, MONÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIETROBON, Anna Julia et al. Antiviral response induced by toll-like receptor (TLR) 7/TLR8 activation inhibits human immunodeficiency virus Type 1 infection in cord blood macrophages. Journal of Infectious Diseases, v. 225, n. 3, p. 510–519, 2022Tradução . . Disponível em: https://doi.org/10.1093/infdis/jiab389. Acesso em: 10 nov. 2024.
APA
Pietrobon, A. J., Yoshikawa, F. S. Y., Oliveira, L. M., Pereira, N. Z., Souza, T. A. M. de, Bargieri, B. C. de A., et al. (2022). Antiviral response induced by toll-like receptor (TLR) 7/TLR8 activation inhibits human immunodeficiency virus Type 1 infection in cord blood macrophages. Journal of Infectious Diseases, 225( 3), 510–519. doi:10.1093/infdis/jiab389
NLM
Pietrobon AJ, Yoshikawa FSY, Oliveira LM, Pereira NZ, Souza TAM de, Bargieri BC de A, Duarte AJ da S, Sato MN. Antiviral response induced by toll-like receptor (TLR) 7/TLR8 activation inhibits human immunodeficiency virus Type 1 infection in cord blood macrophages [Internet]. Journal of Infectious Diseases. 2022 ; 225( 3): 510–519.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1093/infdis/jiab389
Vancouver
Pietrobon AJ, Yoshikawa FSY, Oliveira LM, Pereira NZ, Souza TAM de, Bargieri BC de A, Duarte AJ da S, Sato MN. Antiviral response induced by toll-like receptor (TLR) 7/TLR8 activation inhibits human immunodeficiency virus Type 1 infection in cord blood macrophages [Internet]. Journal of Infectious Diseases. 2022 ; 225( 3): 510–519.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1093/infdis/jiab389
Artigo de periodico
LAMP-1 chimeric to HIV-1 p55Gag in the immunization of neonate mice induces an early germinal center formation and AID expression (2022)
Teixeira, Franciane Mouradian Emidio ; Oliveira, Luana de Mendonça ; Pietrobon, Anna Julia ; Salles, Érika Machado ; Lima, Maria Regina D'Império ; Viana, Isabelle Freire Tabosa; Lins, Roberto Dias ; Rigato, Paula Ordonhez ; Marques, Ernesto Torres de Azevedo ; Duarte, Alberto José da Silva; Sato, Maria Notomi
Fonte: Vaccines. Unidades: ICB, FM
Assuntos: IMUNOLOGIA, RECÉM-NASCIDO, VACINAS VIRAIS, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS, IMUNOGENICIDADE DA VACINA, HIV, DNA VIRAL, LISOSSOMOS, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TEIXEIRA, Franciane Mouradian Emidio et al. LAMP-1 chimeric to HIV-1 p55Gag in the immunization of neonate mice induces an early germinal center formation and AID expression. Vaccines, v. 10, n. 8, p. 14 , 2022Tradução . . Disponível em: https://doi.org/10.3390/vaccines10081246. Acesso em: 10 nov. 2024.
APA
Teixeira, F. M. E., Oliveira, L. de M., Pietrobon, A. J., Salles, É. M., Lima, M. R. D. 'I., Viana, I. F. T., et al. (2022). LAMP-1 chimeric to HIV-1 p55Gag in the immunization of neonate mice induces an early germinal center formation and AID expression. Vaccines, 10( 8), 14 . doi:10.3390/vaccines10081246
NLM
Teixeira FME, Oliveira L de M, Pietrobon AJ, Salles ÉM, Lima MRD'I, Viana IFT, Lins RD, Rigato PO, Marques ET de A, Duarte AJ da S, Sato MN. LAMP-1 chimeric to HIV-1 p55Gag in the immunization of neonate mice induces an early germinal center formation and AID expression [Internet]. Vaccines. 2022 ; 10( 8): 14 .[citado 2024 nov. 10 ] Available from: https://doi.org/10.3390/vaccines10081246
Vancouver
Teixeira FME, Oliveira L de M, Pietrobon AJ, Salles ÉM, Lima MRD'I, Viana IFT, Lins RD, Rigato PO, Marques ET de A, Duarte AJ da S, Sato MN. LAMP-1 chimeric to HIV-1 p55Gag in the immunization of neonate mice induces an early germinal center formation and AID expression [Internet]. Vaccines. 2022 ; 10( 8): 14 .[citado 2024 nov. 10 ] Available from: https://doi.org/10.3390/vaccines10081246
Artigo de periodico
Genetic risk factors and COVID-19 severity in Brazil: results from BRACOVID study (2022)
Pereira, Alexandre C; Bes, Taniela M; Rodrigues, Mariliza Velho ; Marques, Emanuelle; Jannes, Cintia E; Valino, Karina R; Dinardo, Carla L; Costa, Sílvia Figueiredo ; Duarte, Alberto José da Silva; Krieger, Jose Eduardo
Fonte: Human molecular genetics. Unidade: FM
Assuntos: GENÔMICA, COVID-19, FATORES DE RISCO, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Alexandre C et al. Genetic risk factors and COVID-19 severity in Brazil: results from BRACOVID study. Human molecular genetics, v. 31, n. 18, p. 3021-3031, 2022Tradução . . Disponível em: https://doi.org/10.1093/hmg/ddac045. Acesso em: 10 nov. 2024.
APA
Pereira, A. C., Bes, T. M., Rodrigues, M. V., Marques, E., Jannes, C. E., Valino, K. R., et al. (2022). Genetic risk factors and COVID-19 severity in Brazil: results from BRACOVID study. Human molecular genetics, 31( 18), 3021-3031. doi:10.1093/hmg/ddac045
NLM
Pereira AC, Bes TM, Rodrigues MV, Marques E, Jannes CE, Valino KR, Dinardo CL, Costa SF, Duarte AJ da S, Krieger JE. Genetic risk factors and COVID-19 severity in Brazil: results from BRACOVID study [Internet]. Human molecular genetics. 2022 ; 31( 18): 3021-3031.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1093/hmg/ddac045
Vancouver
Pereira AC, Bes TM, Rodrigues MV, Marques E, Jannes CE, Valino KR, Dinardo CL, Costa SF, Duarte AJ da S, Krieger JE. Genetic risk factors and COVID-19 severity in Brazil: results from BRACOVID study [Internet]. Human molecular genetics. 2022 ; 31( 18): 3021-3031.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1093/hmg/ddac045
Artigo de periodico
Severe COVID-19 patients show a dysregulation of the NLRP3 inflammasome in circulating neutrophils (2022)
Leal, Vinicius Nunes Cordeiro ; Andrade, Milena M. S. ; Teixeira, Franciane M. E. ; Cambui, Raylane Adrielle Gonçalves ; Roa, Mariela Estefany Gislene Vera ; Marra, Letícia Girardi ; Yamada, Suemy Melim ; Alberca, Ricardo W. ; Silva, Sarah C. Gozzi ; Yendo, Tatiana M. ; Netto, Lucas C. ; Duarte, Alberto José da Silva; Sato, Maria Notomi ; Pontillo, Alessandra
Fonte: Scandinavian Journal of Immunology. Unidades: FM, ICB
Assuntos: IMUNOLOGIA, CITOCINAS, NEUTRÓFILOS, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Vinicius Nunes Cordeiro et al. Severe COVID-19 patients show a dysregulation of the NLRP3 inflammasome in circulating neutrophils. Scandinavian Journal of Immunology, p. 1-13, 2022Tradução . . Disponível em: https://doi.org/10.1111/sji.13247. Acesso em: 10 nov. 2024.
APA
Leal, V. N. C., Andrade, M. M. S., Teixeira, F. M. E., Cambui, R. A. G., Roa, M. E. G. V., Marra, L. G., et al. (2022). Severe COVID-19 patients show a dysregulation of the NLRP3 inflammasome in circulating neutrophils. Scandinavian Journal of Immunology, 1-13. doi:10.1111/sji.13247
NLM
Leal VNC, Andrade MMS, Teixeira FME, Cambui RAG, Roa MEGV, Marra LG, Yamada SM, Alberca RW, Silva SCG, Yendo TM, Netto LC, Duarte AJ da S, Sato MN, Pontillo A. Severe COVID-19 patients show a dysregulation of the NLRP3 inflammasome in circulating neutrophils [Internet]. Scandinavian Journal of Immunology. 2022 ; 1-13.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1111/sji.13247
Vancouver
Leal VNC, Andrade MMS, Teixeira FME, Cambui RAG, Roa MEGV, Marra LG, Yamada SM, Alberca RW, Silva SCG, Yendo TM, Netto LC, Duarte AJ da S, Sato MN, Pontillo A. Severe COVID-19 patients show a dysregulation of the NLRP3 inflammasome in circulating neutrophils [Internet]. Scandinavian Journal of Immunology. 2022 ; 1-13.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1111/sji.13247
Artigo de periodico
Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients (2022)
Pietrobon, Anna Julia ; Andrejew, Roberta ; Custodio, Ricardo Wesley Alberca ; Oliveira, Luana de Mendonça ; Scholl, Juliete Nathali ; Teixeira, Franciane Mouradian Emidio ; Brito, Cyro Alves de ; Glaser, Talita ; Kazmierski, Julia ; Goffinet, Christine ; Turdo, Anna Claudia; Yendo, Tatiana Mina ; Aoki, Valeria; Figueiró, Fabrício; Battastini, Ana Maria ; Ulrich, Henning ; Benard, Gil ; Duarte, Alberto José da Silva; Sato, Maria Notomi
Fonte: Frontiers in Immunology. Unidades: FM, IQ, ICB
Assuntos: COVID-19, PURINAS, ADENOSINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIETROBON, Anna Julia et al. Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients. Frontiers in Immunology, v. 13, p. 1-12 art. 1012027, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.1012027. Acesso em: 10 nov. 2024.
APA
Pietrobon, A. J., Andrejew, R., Custodio, R. W. A., Oliveira, L. de M., Scholl, J. N., Teixeira, F. M. E., et al. (2022). Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients. Frontiers in Immunology, 13, 1-12 art. 1012027. doi:10.3389/fimmu.2022.1012027
NLM
Pietrobon AJ, Andrejew R, Custodio RWA, Oliveira L de M, Scholl JN, Teixeira FME, Brito CA de, Glaser T, Kazmierski J, Goffinet C, Turdo AC, Yendo TM, Aoki V, Figueiró F, Battastini AM, Ulrich H, Benard G, Duarte AJ da S, Sato MN. Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients [Internet]. Frontiers in Immunology. 2022 ; 13 1-12 art. 1012027.[citado 2024 nov. 10 ] Available from: https://doi.org/10.3389/fimmu.2022.1012027
Vancouver
Pietrobon AJ, Andrejew R, Custodio RWA, Oliveira L de M, Scholl JN, Teixeira FME, Brito CA de, Glaser T, Kazmierski J, Goffinet C, Turdo AC, Yendo TM, Aoki V, Figueiró F, Battastini AM, Ulrich H, Benard G, Duarte AJ da S, Sato MN. Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients [Internet]. Frontiers in Immunology. 2022 ; 13 1-12 art. 1012027.[citado 2024 nov. 10 ] Available from: https://doi.org/10.3389/fimmu.2022.1012027
Artigo de periodico
Predicting the outcome for COVID-19 patients by applying time series classification to electronic health records (2022)
Rodrigues, Davi Silva ; Nastri, Ana Catharina de Seixas Santos ; Magri, Marcello M.; Oliveira, Maura Salaroli de ; Sabino, Ester Cerdeira ; Figueiredo, Pedro H. M. F.; Levin, Anna Sara ; Freire, Maristela P. ; Harima, Leila; Nunes, Fátima L. S.; Ferreira, João Eduardo ; Busatto, Geraldo ; Bonfa, Eloisa Silva Dutra de Oliveira ; Utiyama, Edivaldo Massazo ; Segurado, Aluisio Augusto Cotrim ; Perondi, Beatriz ; Morais, Anna M.; Montal, Amanda ; Fusco, Solange ; Fregonesi, Marjorie; Rocha, Marcelo; Marcílio, Izabel ; Rios, Izabel C; Kawano, Fabiane Y. O.; de Jesus, M. Amelia; Kallas, Esper Georges ; Marmo, Carolina; Tanaka, Clarice ; Souza, Heraldo Possolo de ; Marchini, Julio Flavio ; Carvalho, Carlos; Ferreira, Juliana C.; Guimarães, Thais ; Lazari, Carolina S.; Duarte, Alberto José da Silva; Francisco, M. Cristina P. B.; Costa, Sílvia Figueiredo
Fonte: BMC Medical Informatics and Decision Making. Unidades: FM, EACH, IME, FMRP
Assuntos: COVID-19, SINAIS VITAIS, ANÁLISE DE SÉRIES TEMPORAIS, COMPUTAÇÃO APLICADA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Davi Silva et al. Predicting the outcome for COVID-19 patients by applying time series classification to electronic health records. BMC Medical Informatics and Decision Making, v. 22, n. artigo 187, 2022Tradução . . Disponível em: https://doi.org/10.1186/s12911-022-01931-5. Acesso em: 10 nov. 2024.
APA
Rodrigues, D. S., Nastri, A. C. de S. S., Magri, M. M., Oliveira, M. S. de, Sabino, E. C., Figueiredo, P. H. M. F., et al. (2022). Predicting the outcome for COVID-19 patients by applying time series classification to electronic health records. BMC Medical Informatics and Decision Making, 22( artigo 187). doi:10.1186/s12911-022-01931-5
NLM
Rodrigues DS, Nastri AC de SS, Magri MM, Oliveira MS de, Sabino EC, Figueiredo PHMF, Levin AS, Freire MP, Harima L, Nunes FLS, Ferreira JE, Busatto G, Bonfa ESD de O, Utiyama EM, Segurado AAC, Perondi B, Morais AM, Montal A, Fusco S, Fregonesi M, Rocha M, Marcílio I, Rios IC, Kawano FYO, de Jesus MA, Kallas EG, Marmo C, Tanaka C, Souza HP de, Marchini JF, Carvalho C, Ferreira JC, Guimarães T, Lazari CS, Duarte AJ da S, Francisco MCPB, Costa SF. Predicting the outcome for COVID-19 patients by applying time series classification to electronic health records [Internet]. BMC Medical Informatics and Decision Making. 2022 ; 22( artigo 187):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1186/s12911-022-01931-5
Vancouver
Rodrigues DS, Nastri AC de SS, Magri MM, Oliveira MS de, Sabino EC, Figueiredo PHMF, Levin AS, Freire MP, Harima L, Nunes FLS, Ferreira JE, Busatto G, Bonfa ESD de O, Utiyama EM, Segurado AAC, Perondi B, Morais AM, Montal A, Fusco S, Fregonesi M, Rocha M, Marcílio I, Rios IC, Kawano FYO, de Jesus MA, Kallas EG, Marmo C, Tanaka C, Souza HP de, Marchini JF, Carvalho C, Ferreira JC, Guimarães T, Lazari CS, Duarte AJ da S, Francisco MCPB, Costa SF. Predicting the outcome for COVID-19 patients by applying time series classification to electronic health records [Internet]. BMC Medical Informatics and Decision Making. 2022 ; 22( artigo 187):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1186/s12911-022-01931-5
Artigo de periodico
Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial (2022)
Baptista, Marcella Vassao de Almeida; Silva, Lais Teodoro da; Samer, Sadia; Oshiro, Telma Miyuki; Shytaj, Iart Luca; Giron, Leila B.; Pena, Nathalia Mantovani; Cruz, Nicolly; Cunha Neto, Edecio ; Duarte, Alberto José da Silva
Fonte: Aids research and therapy. Unidade: FM
Assuntos: HIV, IMUNOGENICIDADE DA VACINA, CÉLULAS DENDRÍTICAS, SÍNDROME DE IMUNODEFICIÊNCIA ADQUIRIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BAPTISTA, Marcella Vassao de Almeida et al. Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial. Aids research and therapy, v. 19, n. 1, 2022Tradução . . Disponível em: https://doi.org/10.1186/s12981-021-00426-z. Acesso em: 10 nov. 2024.
APA
Baptista, M. V. de A., Silva, L. T. da, Samer, S., Oshiro, T. M., Shytaj, I. L., Giron, L. B., et al. (2022). Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial. Aids research and therapy, 19( 1). doi:10.1186/s12981-021-00426-z
NLM
Baptista MV de A, Silva LT da, Samer S, Oshiro TM, Shytaj IL, Giron LB, Pena NM, Cruz N, Cunha Neto E, Duarte AJ da S. Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial [Internet]. Aids research and therapy. 2022 ; 19( 1):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1186/s12981-021-00426-z
Vancouver
Baptista MV de A, Silva LT da, Samer S, Oshiro TM, Shytaj IL, Giron LB, Pena NM, Cruz N, Cunha Neto E, Duarte AJ da S. Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial [Internet]. Aids research and therapy. 2022 ; 19( 1):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1186/s12981-021-00426-z
Artigo de periodico-carta/editorial
Patient with agammaglobulinemia produces anti-SARS-CoV-2 reactive T-cells after CoronaVac vaccine [Editorial] (2022)
Oshiro, Telma Miyuki; Silva, Lais Teodoro da; Ortega, Marina Mazzilli; Perazzio, Sandro Felix; Duarte, Alberto José da Silva; Sampaio, Magda Maria Sales Carneiro
Fonte: Clinics. Unidade: FM
Assuntos: VACINAÇÃO, VACINAS VIRAIS, COVID-19, EVENTO ADVERSO A MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OSHIRO, Telma Miyuki et al. Patient with agammaglobulinemia produces anti-SARS-CoV-2 reactive T-cells after CoronaVac vaccine [Editorial]. Clinics. Madrid: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.clinsp.2022.100007. Acesso em: 10 nov. 2024. , 2022
APA
Oshiro, T. M., Silva, L. T. da, Ortega, M. M., Perazzio, S. F., Duarte, A. J. da S., & Sampaio, M. M. S. C. (2022). Patient with agammaglobulinemia produces anti-SARS-CoV-2 reactive T-cells after CoronaVac vaccine [Editorial]. Clinics. Madrid: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.clinsp.2022.100007
NLM
Oshiro TM, Silva LT da, Ortega MM, Perazzio SF, Duarte AJ da S, Sampaio MMSC. Patient with agammaglobulinemia produces anti-SARS-CoV-2 reactive T-cells after CoronaVac vaccine [Editorial] [Internet]. Clinics. 2022 ; 77[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.clinsp.2022.100007
Vancouver
Oshiro TM, Silva LT da, Ortega MM, Perazzio SF, Duarte AJ da S, Sampaio MMSC. Patient with agammaglobulinemia produces anti-SARS-CoV-2 reactive T-cells after CoronaVac vaccine [Editorial] [Internet]. Clinics. 2022 ; 77[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.clinsp.2022.100007
Artigo de periodico
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study (2022)
Aikawa, Nadia E; Kupa, Leonard de Vinci Kanda ; Pasoto, Sandra Gofinet; Shinjo, Samuel Katsuyuki ; Pereira, Rosa Maria Rodrigues ; Sartori, Ana Marli Christovam ; Duarte, Alberto José da Silva; Antonangelo, Leila ; Sabino, Ester Cerdeira ; Menezes, Paulo Rossi ; Kallas, Esper Georges ; Silva, Clovis Artur Almeida da ; Bonfa, Eloisa Silva Dutra de Oliveira
Fonte: Lancet rheumatology. Unidade: FM
Assuntos: IMUNOGENÉTICA, COVID-19, SISTEMA IMUNE, IMUNOGENICIDADE DA VACINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AIKAWA, Nadia E et al. Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study. Lancet rheumatology, v. 4, n. 2, p. E113-E124, 2022Tradução . . Disponível em: https://doi.org/10.1016/S2665-9913(21)00327-1. Acesso em: 10 nov. 2024.
APA
Aikawa, N. E., Kupa, L. de V. K., Pasoto, S. G., Shinjo, S. K., Pereira, R. M. R., Sartori, A. M. C., et al. (2022). Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study. Lancet rheumatology, 4( 2), E113-E124. doi:10.1016/S2665-9913(21)00327-1
NLM
Aikawa NE, Kupa L de VK, Pasoto SG, Shinjo SK, Pereira RMR, Sartori AMC, Duarte AJ da S, Antonangelo L, Sabino EC, Menezes PR, Kallas EG, Silva CAA da, Bonfa ESD de O. Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study [Internet]. Lancet rheumatology. 2022 ; 4( 2): E113-E124.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/S2665-9913(21)00327-1
Vancouver
Aikawa NE, Kupa L de VK, Pasoto SG, Shinjo SK, Pereira RMR, Sartori AMC, Duarte AJ da S, Antonangelo L, Sabino EC, Menezes PR, Kallas EG, Silva CAA da, Bonfa ESD de O. Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study [Internet]. Lancet rheumatology. 2022 ; 4( 2): E113-E124.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/S2665-9913(21)00327-1
Artigo de periodico
Age-associated phenotypic imbalance in TCD4 and TCD8 cell subsets: comparison between healthy aged, smokers, COPD patients and young adults (2022)
Fernandes, Juliana Ruiz; Pinto, Thalyta Nery Carvalho; Arruda, Lia Barbara; Silva, Cibele Cristine Berto Marques da ; Carvalho, Celso Ricardo Fernandes de ; Pinto, Regina Maria Carvalho; Duarte, Alberto José da Silva; Benard, Gil
Fonte: Immunity & ageing. Unidade: FM
Assuntos: TABAGISMO, DOENÇA PULMONAR OBSTRUTIVA CRÔNICA, ADULTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Juliana Ruiz et al. Age-associated phenotypic imbalance in TCD4 and TCD8 cell subsets: comparison between healthy aged, smokers, COPD patients and young adults. Immunity & ageing, v. 19, n. 1, 2022Tradução . . Disponível em: https://doi.org/10.1186/s12979-022-00267-y. Acesso em: 10 nov. 2024.
APA
Fernandes, J. R., Pinto, T. N. C., Arruda, L. B., Silva, C. C. B. M. da, Carvalho, C. R. F. de, Pinto, R. M. C., et al. (2022). Age-associated phenotypic imbalance in TCD4 and TCD8 cell subsets: comparison between healthy aged, smokers, COPD patients and young adults. Immunity & ageing, 19( 1). doi:10.1186/s12979-022-00267-y
NLM
Fernandes JR, Pinto TNC, Arruda LB, Silva CCBM da, Carvalho CRF de, Pinto RMC, Duarte AJ da S, Benard G. Age-associated phenotypic imbalance in TCD4 and TCD8 cell subsets: comparison between healthy aged, smokers, COPD patients and young adults [Internet]. Immunity & ageing. 2022 ; 19( 1):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1186/s12979-022-00267-y
Vancouver
Fernandes JR, Pinto TNC, Arruda LB, Silva CCBM da, Carvalho CRF de, Pinto RMC, Duarte AJ da S, Benard G. Age-associated phenotypic imbalance in TCD4 and TCD8 cell subsets: comparison between healthy aged, smokers, COPD patients and young adults [Internet]. Immunity & ageing. 2022 ; 19( 1):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1186/s12979-022-00267-y

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Assuntos

Título da fonte

País de publicação

Agência de fomento

Afiliação dos autores externos não normalizada